Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Current Assets (2016 - 2021)

Phio Pharmaceuticals' Current Assets history spans 10 years, with the latest figure at $27.4 million for Q3 2021.

  • For Q3 2021, Current Assets rose 55.79% year-over-year to $27.4 million; the TTM value through Sep 2021 reached $27.4 million, up 55.79%, while the annual FY2020 figure was $15.2 million, 107.73% up from the prior year.
  • Current Assets reached $27.4 million in Q3 2021 per PHIO's latest filing, down from $31.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $33.3 million in Q1 2021 to a low of $2.9 million in Q1 2018.
  • Average Current Assets over 5 years is $13.4 million, with a median of $11.4 million recorded in 2019.
  • Peak YoY movement for Current Assets: plummeted 72.43% in 2018, then soared 351.19% in 2019.
  • A 5-year view of Current Assets shows it stood at $3.8 million in 2017, then skyrocketed by 295.35% to $15.2 million in 2018, then crashed by 51.82% to $7.3 million in 2019, then soared by 107.73% to $15.2 million in 2020, then surged by 81.02% to $27.4 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Current Assets are $27.4 million (Q3 2021), $31.2 million (Q2 2021), and $33.3 million (Q1 2021).